Academic Department of Rehabilitation Medicine, The University of Leeds, UK.
J Rehabil Med. 2011 Nov;43(11):1010-5. doi: 10.2340/16501977-0893.
To define a sub-set of functional goals and outcomes relevant to children and families living with cerebral palsy following treatment with botulinum toxin type A using the International Classification of Functioning, Disability and Health for Children and Youth.
We identified treatment goals and treatment outcomes from medical case records in 2102 assessments of 239 children with cerebral palsy treated with botulinum toxin between 1994 and 2009. Goals were set through assessment and discussion by experienced clinicians, therapists, parents and children.
There were 61 separate goals, mapping to 40 categories, falling mostly within Body Functions: b710 Mobility of joint functions (414 times); b770 Gait pattern functions (374 times); b7351 Tone of muscles of one limb (117 times). A total of 93 separate treatment outcomes were identified, mapping to 51 categories. Two of the 3 most common outcomes correspond to the 2 most common goals (gait pattern and mobility of joint functions).
The International Classification of Functioning, Disability and Health for Children and Youth provides a useful framework to categorize the reasons for using botulinum toxin in children and focuses the clinical consultation not only on impairments but also functional outcomes.
使用《国际功能、残疾和健康分类儿童和青年版》，为脑瘫患儿接受 A 型肉毒毒素治疗后与生活相关的功能目标和结局定义一个亚组。
我们从 1994 年至 2009 年期间 239 名脑瘫患儿的 2102 次评估的病历记录中确定了治疗目标和治疗结果。通过经验丰富的临床医生、治疗师、家长和孩子的评估和讨论来制定目标。
共有 61 个独立的目标，映射到 40 个类别，主要集中在身体功能领域：b710 关节运动功能（414 次）；b770 步态模式功能（374 次）；b7351 单肢肌肉张力（117 次）。共确定了 93 个独立的治疗结果，映射到 51 个类别。3 个最常见的结果中的 2 个对应于 2 个最常见的目标（步态模式和关节运动功能）。
《国际功能、残疾和健康分类儿童和青年版》为在儿童中使用肉毒毒素的原因提供了一个有用的分类框架，并将临床咨询重点不仅放在损伤上，还放在功能结果上。
